Physician profile
Karen Kim
NPI 1548231764
$3,732.81
in general payments reported to CMS, 2019-2025
22 companies · $301 in 2025
The $301 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $702 · 2020: $845 · 2021: $443 · 2022: $360 · 2023: $438 · 2024: $643 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,383.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,145.31 | 2019-2025 | |
| Amgen INC. | $1,130.26 | 2019-2025 | Evenity, Prolia, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $189.11 | 2019-2020 | |
| Cvrx, INC. | $169.05 | 2024 | Barostim Neo System |
| Amarin Pharma, INC. | $147.42 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $135.32 | 2020 | |
| Lilly USA, LLC | $124.26 | 2019-2025 | Mounjaro, Zepbound |
| Allergan, INC. | $86.27 | 2020 | |
| Shire North American Group INC | $85.31 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $80.63 | 2019-2021 | |
| Esperion Therapeutics, INC. | $78.08 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $73.70 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $38.61 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $34.89 | 2025 | Voquezna |
| Glaxosmithkline, LLC. | $31.83 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Uswm, LLC | $31.18 | 2025 | Iwilfin |
| Novo Nordisk INC | $30.94 | 2025 | Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.88 | 2021 | |
| United Therapeutics Corporation | $26.95 | 2024 | Unituxin |
| Hologic Sales and Service, LLC | $24.58 | 2025 | Aptima |
| Amphastar Pharmaceuticals, INC. | $22.11 | 2025 | |
| Exact Sciences Corporation | $19.12 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.